Nucleus Genomics
PrivateLast Round
Series A
Jan 30, 2025
Total Funding Raised
$31.5M
Company Overview
Nucleus Genomics is a biotechnology company that provides direct-to-consumer whole-genome sequencing and analysis for health risks, family planning, and preventative health.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleus Genomics Comps
Public and private peers based on sector, stage, and business model.
Nucleus Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2025 | ||||
| Seed | Jul 14, 2022 | ||||
| Pre Seed | Dec 15, 2021 |
Nucleus Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rose Street Capital | Series A |
| Neo | Series A |
| Founders Fund | Seed, Series A, Pre Seed |
| Asylum Ventures | Series A |
| Seven Seven Six | Seed, Series A |
| Common Metal | Series A |
| Samsung Next TLV | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2025
$14M round led by Founders Fund and Seven Seven Six.
- Jul 14, 2022
$14M round led by Seven Seven Six.
Nucleus Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleus Genomics's valuation, stock price, and market status.
